XML 12 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK COMPENSATION PLANS (Tables)
9 Months Ended
Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Unrecognized Share-Based Compensation Expense
The following table presents unrecognized share-based compensation expense as of September 30, 2014:
 
 
Unrecognized
Expense
 
Average
Expected
Recognition
Period
 
($ in thousands)
Stock option awards
$
1,193

 
3.3 years
Restricted stock awards and restricted stock units
11,079

 
3.5 years
Total
$
12,272

 
3.5 years
Option Activity
The following table represents stock option activity as of and for the three months ended September 30, 2014:
 
 
Number of
Shares
 
Weighted-
Average
Exercise
Price per
Share
 
Weighted-
Average
Remaining
Contract
Term
 
Aggregated
Intrinsic
Value
(In thousands) 
Outstanding at beginning of period
818,054

 
$
12.75

 
7.5 years
 
$

Granted
81,016

 
$
11.65

 
9.8 years
 
$
22

Exercised
(20,000
)
 
$
11.78

 
 
 
 
Outstanding at end of period
879,070

 
$
12.67

 
7.5 years
 
$
59

Exercisable at end of period
206,016

 
$
11.34

 
7.4 years
 
$
59

The following table represents stock option activity as of and for the nine months ended September 30, 2014:
 
 
Number of
Shares
 
Weighted-
Average
Exercise
Price per
Share
 
Weighted-
Average
Remaining
Contract
Term
 
Aggregated
Intrinsic
Value
(In thousands) 
Outstanding at beginning of period
734,721

 
$
12.73

 
7.5 years
 
$
741

Granted
231,016

 
$
12.05

 
9.6 years
 
$
22

Exercised
(86,667
)
 
$
11.46

 

 


Outstanding at end of period
879,070

 
$
12.67

 
7.5 years
 
$
59

Exercisable at end of period
206,016

 
$
11.34

 
7.4 years
 
$
59

Nonvested Share
The following table represents changes in unvested stock options and related information as of and for the three and nine months ended September 30, 2014:
 
 
Three Months Ended 
 September 30, 2014
 
Nine Months Ended 
 September 30, 2014
Number
of Shares
 
Weighted-
Average
Exercise
Price per
Share
 
Number
of Shares
 
Weighted-
Average
Exercise
Price per
Share
Non-vested outstanding at beginning of period
544,569

 
$
12.93

 
419,569

 
$
13.16

Granted
81,016

 
$
11.65

 
231,016

 
$
12.05

Vested
(20,000
)
 
$
12.64

 
(45,000
)
 
$
12.76

Non-vested outstanding at end of period
605,585

 
$
12.77

 
605,585

 
$
12.77

Restricted Stock and Restricted Stock Units Activity
The following table represents restricted stock awards and restricted stock units activity as of and for the three and nine months ended September 30, 2014:
 
 
Three Months Ended 
 September 30, 2014
 
Nine Months Ended 
 September 30, 2014
Number of
Shares
 
Weighted-
Average
Price per
Share
 
Number of
Shares
 
Weighted-
Average
Price per
Share
Non-vested shares outstanding at beginning of period
1,276,453

 
$
12.93

 
893,886

 
$
13.78

Granted
154,981

 
$
11.47

 
798,460

 
$
11.83

Vested
(37,477
)
 
$
14.03

 
(137,268
)
 
$
13.55

Forfeited
(58,975
)
 
$
13.43

 
(220,096
)
 
$
13.31

Non-vested shares outstanding at end of period
1,334,982

 
$
12.70

 
1,334,982

 
$
12.70

Summary of all Outstanding SARs
The following table represents a summary of all outstanding SARs (Initial SAR, Additional SARs and Additional SAR VI, together the SARs):
 
 
Initial SAR
 
Additional

SAR I
(1)
 
Additional

SAR II
(2)
 
Additional

SAR III
(3)
 
Additional

SAR IV
(4)
 
Additional

SAR V
(5)
 
Additional

SAR VI
(6)
Grant Date
8/21/2012

 
6/21/2013

 
7/1/2013

 
7/2/2013

 
12/10/2013

 
5/21/2014

 
5/21/2014

Number of shares
500,000

 
150,933

 
88,366

 
15,275

 
70,877

 
252,023

 
289,116

Base price per share
$
12.12

 
$
13.06

 
$
13.60

 
$
13.55

 
$
12.83

 
$
10.09

 
$
10.09

Grant date fair value per share
$
3.58

 
$
1.86

 
$
1.94

 
$
1.93

 
$
1.86

 
$
1.22

 
$
1.58

 
(1)
Issued due to the Company’s common stock issuance for an underwritten public offering completed on June 21, 2013.
(2)
Issued due to the Company’s common stock issuance in connection with the PBOC acquisition completed on July 1, 2013.
(3)
Issued due to the Company’s common stock issuance for the exercise of over-allotment option granted to the underwriters of the Company’s public common stock offering initially completed on June 21, 2013.
(4)
Issued due to the Company’s common stock issuance in a private placement completed on December 10, 2013.
(5)
Issued due to the Company’s common stock issuance for an underwritten public offering completed on May 21, 2014.
(6)
The Additional SAR VI originally related to 300,219 shares of common stock with a scheduled vesting of May 21, 2017, as described above. As a result of the settlements of portions of the Purchase Contacts, the Additional SAR VI accelerated in vesting with respect to 81,979 shares and 11,103 shares were forfeited as of September 30, 2014. A portion of Additional SAR VI that has accelerated in vesting has the same terms and conditions as the Initial SAR.